• Sun. Jun 14th, 2026

Month: January 2026

  • Home
  • We discuss possible reasons for the lack of efficacy of ICB in UM compared to CM, highlight the pitfalls of ICB in this cancer entity, and explain why other immune-modulating therapies could still be an option for future UM therapies

We discuss possible reasons for the lack of efficacy of ICB in UM compared to CM, highlight the pitfalls of ICB in this cancer entity, and explain why other immune-modulating therapies could still be an option for future UM therapies

We discuss possible reasons for the lack of efficacy of ICB in UM compared to CM, highlight the pitfalls of ICB in this cancer entity, and explain why other immune-modulating…

The safety data were used to support initiation of trials in > 300 infants in Kenya and Equatorial Guinea

The safety data were used to support initiation of trials in > 300 infants in Kenya and Equatorial Guinea. lowest in adults. T-cell responses were highest Methoxsalen (Oxsoralen) in 610-12…

Therefore mortality of PNS may be reduced with rapid antibody detection, early treatment, and a standard immunotherapy protocol

Therefore mortality of PNS may be reduced with rapid antibody detection, early treatment, and a standard immunotherapy protocol. Another notable finding was that positivity for extracellular and synaptic antibodies predicted…

MST, median survival time

MST, median survival time. Number 8outlines the overall study schema to compare BLS with FGS under GFP navigation and FGS under anti-CEA-DyLight650 navigation. == Fig. statement, we demonstrate that an…